Regulatory and Research Status Both BPC-157 and TB-500 have not been approved for human use by the MHRA, and similar agency, because there is no adequate clinical data on them on a large scale
The results are not directly comparable because the peptides are not equivalent products
Follow-up appointments are often shorter, depending on the services included
By inhibiting NNMT, research suggests that 5-Amino-1MQ may help enhance NAD+ availability, which has downstream implications in metabolic health and mitochondrial function
The most useful strategy is to match testing with age, prior results, family history, medical conditions, symptoms, medications, and the decision the result may help guide
If other vitamin deficiencies are present, they should be treated